Estimating the impact of the first 2 years of the COVID-19 pandemic on tuberculosis diagnosis and treatment outcomes in Southeastern City in Iran: an interrupted time series analysis of the preceding 10 years of ecological data.

Publication date: Nov 28, 2024

With shared modes of transmission and clinical symptoms the convergence of COVID-19 and tuberculosis (TB) might lead to reduced diagnosis and detection of TB, which is challenging for healthcare systems already strained by the pandemic’s reach. This ecological study investigated the impact of the COVID-19 pandemic on TB surveillance over the first 2 years of the pandemic (March 2020 to February 2022) in southeastern Iran. Interrupted Time Series (ITS) analysis with the quasi-Poisson regression models was used to estimate the relative risk (RR) of TB diagnosis and treatment outcome counts, stratified by gender, case definition, involvement type, and treatment outcomes. The ITS analyses showed a significant decrease in TB total cases (RR: 0. 622 [95% CI: 0. 487, 0. 793], P 

Open Access PDF

Concepts Keywords
10years Adult
Iran COVID-19
Models COVID-19
Tuberculosis Extrapulmonary TB
Female
Humans
Interrupted time series
Iran
Male
Pandemics
Pulmonary TB
Quasi-poisson regression
Relative risk
SARS-CoV-2
Treatment Outcome
Tuberculosis

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH tuberculosis
pathway KEGG Tuberculosis
pathway REACTOME Reproduction
disease MESH treatment failure
drug DRUGBANK Trestolone
disease MESH death
drug DRUGBANK Coenzyme M
disease MESH infectious diseases
disease MESH social stigma
disease MESH treatment delays
disease MESH phobia
drug DRUGBANK Spinosad
disease MESH infections
disease MESH misdiagnosis
drug DRUGBANK Tretamine
disease MESH recurrence
disease IDO intervention
disease MESH unemployment
disease IDO country
disease MESH anxiety
disease MESH latent infection
disease MESH Coinfection
drug DRUGBANK Indoleacetic acid
disease MESH Hypertension
disease MESH breast cancer
pathway KEGG Breast cancer
disease IDO symptom
disease MESH non communicable diseases
disease MESH pulmonary tuberculosis
disease MESH schizophrenia
drug DRUGBANK Dapsone
disease MESH influenza
disease MESH AIDS

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *